Upadacitinib Beats Methotrexate in Early Rheumatoid Arthritis

WEDNESDAY, July 8, 2020 -- Upadacitinib monotherapy results in improved outcomes versus methotrexate for patients with predominantly early rheumatoid arthritis, according to a study published online July 8 in Arthritis& Rheumatology.
Ronald van...

Source: Drugs.com - Pharma News - July 8, 2020 Category: Pharmaceuticals Source Type: news